Literature DB >> 2550117

Effect of gallium on the in vitro formation, growth, and solubility of hydroxyapatite.

N C Blumenthal1, V Cosma, S Levine.   

Abstract

Gallium (Ga) is an effective treatment for the hypercalcemia of malignancy. The mechanism of action of the metal in blocking bone resorption in humans is not well understood. This paper examines the effect of Ga on the in vitro formation of hydroxyapatite (HA) in three test systems that have possible biological relevance in a pH-stat at pH 7.4, 37 degrees C, and 0.15 M NaCl: (1) the direct precipitation of HA; (2) the transformation of amorphous calcium phosphate to HA; and (3) the growth of HA seeds. In addition, the effect of Ga on HA solubility was measured at pH 5.0, the approximate pH of osteoclastic bone resorption. Ga decreased the HA formation and/or growth kinetics in a dose-related manner in all three test systems. In addition, the time to the onset of HA formation was increased in systems 1 and 2. Also, the adsorption of Ga on the surface of HA crystals was measured. Ga reduced the dissolution kinetics of HA compared with Ga-free control. The mechanism reported herein--the significant adsorption of Ga on forming and growing HA nuclei and on the surface of HA crystals--is believed to be responsible for the effects of the metal on HA proliferation and solubility. Accumulation of the metal on newly formed metaphyseal bone can now be explained by this adsorption of Ga. These in vitro results partly explain the in vivo action of Ga in treating hypercalcemia by decreasing bone apatite solubility.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2550117     DOI: 10.1007/BF02561406

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN: 0171-967X            Impact factor:   4.333


  12 in total

1.  Atomic structure of intracellular amorphous calcium phosphate deposits.

Authors:  F Betts; N C Blumenthal; A S Posner; G L Becker; A L Lehninger
Journal:  Proc Natl Acad Sci U S A       Date:  1975-06       Impact factor: 11.205

2.  Effect of carbonate and biological macromolecules on formation and properties of hydroxyapatite.

Authors:  N C Blumenthal; F Betts; A S Posner
Journal:  Calcif Tissue Res       Date:  1975-07-25

3.  Stabilization of amorphous calcium phosphate by Mg and ATP.

Authors:  N C Blumenthal; F Betts; A S Posner
Journal:  Calcif Tissue Res       Date:  1977-10-20

4.  The ulstrastructure of the extracellular phase of bone as observed in frozen thin sections.

Authors:  C V Gay
Journal:  Calcif Tissue Res       Date:  1977-10-20

5.  Electron diffraction and electron probe microanalysis of the mineral phase of bone tissue prepared by anhydrous techniques.

Authors:  W J Landis; M J Glimcher
Journal:  J Ultrastruct Res       Date:  1978-05

6.  In vitro model of aluminum-induced osteomalacia: inhibition of hydroxyapatite formation and growth.

Authors:  N C Blumenthal; A S Posner
Journal:  Calcif Tissue Int       Date:  1984-07       Impact factor: 4.333

7.  Bone aluminum and histomorphometric features of renal osteodystrophy.

Authors:  A B Hodsman; D J Sherrard; A C Alfrey; S Ott; A S Brickman; N L Miller; N A Maloney; J W Coburn
Journal:  J Clin Endocrinol Metab       Date:  1982-03       Impact factor: 5.958

8.  Gallium nitrate inhibits calcium resorption from bone and is effective treatment for cancer-related hypercalcemia.

Authors:  R P Warrell; R S Bockman; C J Coonley; M Isaacs; H Staszewski
Journal:  J Clin Invest       Date:  1984-05       Impact factor: 14.808

9.  Amorphous calcium phosphate in casein micelles of bovine milk.

Authors:  T C McGann; R D Kearney; W Buchheim; A S Posner; F Betts; N C Blumenthal
Journal:  Calcif Tissue Int       Date:  1983-09       Impact factor: 4.333

10.  Diphosphonates inhibit hydroxyapatite dissolution in vitro and bone resorption in tissue culture and in vivo.

Authors:  H Fleisch; R G Russell; M D Francis
Journal:  Science       Date:  1969-09-19       Impact factor: 47.728

View more
  8 in total

Review 1.  Gallium nitrate. A review of its pharmacological properties and therapeutic potential in cancer related hypercalcaemia.

Authors:  P A Todd; A Fitton
Journal:  Drugs       Date:  1991-08       Impact factor: 9.546

Review 2.  Drugs used in the treatment of metabolic bone disease. Clinical pharmacology and therapeutic use.

Authors:  S Patel; A R Lyons; D J Hosking
Journal:  Drugs       Date:  1993-10       Impact factor: 9.546

3.  The effect of cadmium on the formation and properties of hydroxyapatite in vitro and its relation to cadmium toxicity in the skeletal system.

Authors:  N C Blumenthal; V Cosma; D Skyler; J LeGeros; M Walters
Journal:  Calcif Tissue Int       Date:  1995-04       Impact factor: 4.333

4.  Antibacterial properties of poly (octanediol citrate)/gallium-containing bioglass composite scaffolds.

Authors:  Ehsan Zeimaran; Sara Pourshahrestani; Ivan Djordjevic; Belinda Pingguan-Murphy; Nahrizul Adib Kadri; Anthony W Wren; Mark R Towler
Journal:  J Mater Sci Mater Med       Date:  2015-12-16       Impact factor: 3.896

5.  Bone tissue incorporates in vitro gallium with a local structure similar to gallium-doped brushite.

Authors:  M Korbas; E Rokita; W Meyer-Klaucke; J Ryczek
Journal:  J Biol Inorg Chem       Date:  2003-11-29       Impact factor: 3.358

6.  Two-in-One Biointerfaces-Antimicrobial and Bioactive Nanoporous Gallium Titanate Layers for Titanium Implants.

Authors:  Seiji Yamaguchi; Shekhar Nath; Yoko Sugawara; Kamini Divakarla; Theerthankar Das; Jim Manos; Wojciech Chrzanowski; Tomiharu Matsushita; Tadashi Kokubo
Journal:  Nanomaterials (Basel)       Date:  2017-08-20       Impact factor: 5.076

7.  Gallium ions promote osteoinduction of human and mouse osteoblasts via the TRPM7/Akt signaling pathway.

Authors:  Mingyang Yu; Yunguang Wang; Yao Zhang; Daping Cui; Guishan Gu; Dewei Zhao
Journal:  Mol Med Rep       Date:  2020-07-16       Impact factor: 2.952

Review 8.  Gallium containing bioactive materials: A review of anticancer, antibacterial, and osteogenic properties.

Authors:  Fatih Kurtuldu; Nurshen Mutlu; Aldo R Boccaccini; Dušan Galusek
Journal:  Bioact Mater       Date:  2022-01-10
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.